News

Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss drug Zepbound through a new partnership with Eli Lilly.
According to Ro’s site, the lower-dose version of the Zepbound vials costs $399 a month and the higher-dose version costs $549 a month. Lilly’s deal appears to be an effort to get a toehold in ...
Direct-to-consumer health-care startup Ro said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly.
Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s. Vials of the weight loss therapy will be made available through the telehealth platform ...
Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Eli Lilly will partner only with telehealth firms that agree to stop selling compound versions of its drug Zepbound or Novo Nordisk’s Wegovy, a move that sidelines Hims & Hers Health, Bloomberg ...
While Ro’s policies won’t cover the program costs, ... Eli Lilly, the manufacturer of Zepbound, made Zepbound available on its online pharmacy, LillyDirect, in August 2024.
In December of last year, Ro announced an agreement with Lilly to provide Zepbound single-dose vials through Lilly’s pharmacy channel. 3. In a press release issued at the time, Patrik Jonsson, ... Ro ...
Ro is a telehealth company. To get Zepbound from Ro, you must join the company’s Body Program. This program offers prescription weight loss drugs, coaching and ongoing support, and an insurance ...